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The association of low birth weight and chronic kidney
disease was examined in a screened volunteer population by
the National Kidney Foundation’s Kidney Early Evaluation
Program. This is a free, community-based health program
enrolling individuals aged 18 years or older with diabetes,
hypertension, or a family history of kidney disease, diabetes,
or hypertension. Self-reported birth weight was categorized
and chronic kidney disease defined as an estimated
glomerular filtration rate less than 60 ml per min per 1.73 m2
or a urine albumin/creatinine ratioX30 mg/g. Among 12 364
participants, 15% reported a birth weight less than 2500 g. In
men, significant corresponding odds ratios were found after
adjustment for demographic characteristics and health
conditions to this low birth weight and chronic kidney
disease, but there was no association among women. There
was no significant interaction between birth weight and race
for either gender. Efforts to clinically understand the etiology
of this association and potential means of prevention are
essential to improving public health.
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Low birth weight has been hypothesized to lead to systemic
arterial hypertension and chronic kidney disease (CKD) in
adult life.1,2 Evidence has shown a direct relationship between
birth weight and nephron number.3–6 Some studies showed
that birth weight was positively associated with glomerular
filtration rate (GFR)7,8 and negatively associated with serum
creatinine level.7 The association of low birth weight and
increased risk of urinary albumin excretion measured by
albumin/creatinine ratio (ACR; 30 mg/g or greater) was
observed among Pima Indians with type II diabetes mellitus9
and among Aborigines living in Australia.10 Finally, the
association between low birth weight and end-stage renal
disease was confirmed in the southeastern United States11
and among young adults with diabetes or hypertension in the
Medicaid population.12
Study samples described in published studies of the
association of low birth weight and CKD in adult life are
rather small in size or limited to specific racial or ethnic
groups. The Kidney Early Evaluation Program (KEEP),
conducted by the National Kidney Foundation, is the first
national study that targets adult populations at high risk for
CKD. KEEP is a free, community-based screening program
for CKD, enrolling individuals aged 18 years or older with a
personal history of diabetes or hypertension or with a first-
degree relative with kidney disease, diabetes, or hypertension.
As part of the routine evaluation, participants are asked to
recall their birth weights. Since its origin in 1997, KEEP
has screened more than 70 000 participants in 48 states.
Therefore, a large geographically, racially, and ethnically
diverse population is now available to study the association
between birth weight and prevalent CKD.
RESULTS
Among the 12 364 eligible KEEP participants included in this
study, mean age was 49.1 years (s.d., 13.5); 28.7% were
African American and 76.4% female. More than two-thirds
of participants reported post-high-school education.
Overall, 84.4% had health insurance coverage, 23.2%
had been previously diagnosed with diabetes, 48.1%
had been told that they had high blood pressure, 16.2% had
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cardiovascular disease, and 23.7% had a family member with
kidney disease.
The mean reported birth weight was 3195 g (median,
3175; s.d., 781). The distribution of participants in
birth-weight categories stratified on gender is presented
in Figure 1. The distributions of birth-weight categories
within each characteristic are shown in Table 1. The 1845
participants whose birth weight was less than 2500 g were
more likely to be African American or female, to have lower
educational levels, and to report pre-existing comorbid
conditions (diabetes, hypertension, or cardiovascular dis-
ease). Participants with high birth weights were more likely to
have diabetic mothers.
We tested the interactions between birth weight and
gender or race in the associations with CKD. The interaction
between birth weight and gender was significant before
adjustment for covariates (P¼ 0.03). Therefore, we present
the prevalence of each of three kidney disease outcomes by
birth-weight categories after gender stratification in Table 2.
The prevalence of kidney disease outcomes is also presented
for white and African American participants within each
gender. By gender, a U-shaped trend was evident for all
kidney disease outcomes for men but not for women; men
with low birth weight (o2500 g) or high birth weight
(X4500 g) had significantly higher prevalence of each of the
three kidney disease outcomes than men with normal birth
weight (2500–4499 g). The association of birth weight with
kidney disease outcomes was evident for white but not for
African American men. However, the three-way interaction
among birth weight, gender, and race was not significant.
The interaction between birth weight and gender was still
significant after adjustment for age; race; self-reported
diabetes, hypertension, or cardiovascular disease; family
history of kidney disease; region; education; insurance status;
and hypertension control (P¼ 0.03). Adjusted odds ratios of
CKD by gender and birth weight are presented in Figure 2 for
men and Figure 3 for women. The U-shaped association
between birth weight and CKD was still evident for men after
controlling for covariates. Compared with men whose birth
weight was between 3000 and 3999 g, those whose
birth weight was less than 2500 g had 1.65-fold odds (95%
confidence interval 1.24–2.20) of CKD and those with birth
weight 4500 g and more had 1.41-fold odds (95% confidence
interval 1.06–1.88) of CKD. Older age and a history of disease
were significantly positively associated with CKD prevalence.
Race identified as African American, region other than south,
and hypertension control were significantly negatively
associated with CKD prevalence.
DISCUSSION
In this study, we demonstrate in a large population, aged
18–75 years, with a history of diabetes or hypertension or a
family history of diabetes, hypertension, or kidney disease, a
U-shaped association between birth-weight categories and
several kidney disease outcomes among men but not women.
These associations persisted despite multivariable adjustment
for several other important kidney disease risk factors, and
were similar in further stratifications on race within each
gender. These findings are important in better identifying
high-risk populations at an early stage in an effort to stem the
epidemic of CKD.
In part, our findings showing the association of low and
high birth weight with CKD are consistent with prior studies.
Our finding of a strong association of low birth weight with
kidney disease is consistent with several previous studies.9–12
Our finding of an association between high birth weight and
higher prevalence of CKD is partially consistent with two
prior studies.9,11 Nelson et al.9 found a U-shaped association
between birth weight and prevalence of elevated urinary
albumin levels defined by ACR 30 mg/g or greater in 308
Pima Indians aged 20–61 years with type II diabetes. In that
study, subjects with birth weight o2500 g had a significantly
higher risk of ACR 30 mg/g or greater than those with normal
birth weight. The association between birth weight X4500 g
and a higher risk of ACR 30 mg/g or greater became
insignificant after adjusting for gender, duration of diabetes,
HbA1c value, and blood pressure.9 However, these authors
did not find a gender interaction. In a case–control study of
the association of birth weight and end-stage renal disease,
Lackland et al.11 also found a U-shaped relationship, with the
highest odds ratio of renal failure in the lowest birth weight
group. There was no association between birth weight
X4000 g and higher prevalence of renal failure in men (odds
ratio 1.0). In women, birth weight X4000 g was associated
with a higher risk of renal failure but it was insignificant
(odds ratio 1.4, 95% confidence interval 0.8–2.4). However,
the association between birth weightX4000 g and higher risk
of renal failure was significant for persons with diabetes as
the primary cause of end-stage renal disease (odds ratio 2.4,
95% confidence interval 1.3–4.2).11
Researchers have hypothesized potential mechanisms
leading to kidney disease in persons with low birth
weight.1,2,13,14 For example, Brenner and Chertow2 hypothe-
sized that low birth weight due to intrauterine growth
retardation or premature birth leads to impaired renal
development, which reduces filtration surface area, and
therefore leads to systemic glomerular hypertension, further
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Figure 1 | Distribution of participants in birth-weight categories.
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developing to renal failure. Much evidence showed a direct
relationship between birth weight and nephron number and
an inverse relationship between birth weight and glomerular
size.3–6 A correlation between nephron number, low birth
weight, and hypertension was also reported.3,4
High birth weight may imply macrosomia and diabetes
or insulin resistance in the mother, and hence genetic
predisposition for future CKD. The association of high birth
weight and a history of maternal diabetes was also observed
in our study.
Our database was large enough to demonstrate two
important ideas: (1) low birth weight, probably mediated
through low nephron mass, is associated with CKD in later
adulthood; and (2) high birth weight, probably due to its
association with maternal and future insulin resistance and
hypertension, is also associated with future CKD.
Our finding that the association of birth weight and CKD
depends on gender is new and unexpected. The U-shaped
relationship of birth weight and CKD was significant at both
ends for men but not for women in the KEEP population.
This contrasts with some findings of a study conducted in the
southeastern United States.11 In studying the association of
birth weight and end-stage renal disease, Lackland et al.11
found that low birth weight, less than 2500 g, is significantly
Table 1 | Characteristics of KEEP participants by birth-weight categories (N=12 364)a
Birth weight (g)
o2500 2500–2999 3000–3999 4000–4499 X4500
n=1845 n=2449 n=6251 n=1054 n=765 Pb
Age (years) 49.6±13.0 48.9±13.0 48.6±13.6 50.0±14.0 51.8±13.8 0.0135
Race o0.0001
White 13.9 18.5 51.9 9.6 6.1
African American 16.7 22.2 47.6 7.2 6.3
Other race 15.7 20.1 51.0 6.9 6.2
Gender o0.0001
Female 16.1 21.7 50.9 6.8 4.4
Male 11.1 13.6 49.4 14.0 11.9
Insurance 0.5024
No 16.0 20.3 49.3 8.1 6.3
Yes 14.7 19.7 50.8 8.6 6.2
Education 0.0122
p12 years 15.7 19.4 49.3 8.4 7.1
412 years 14.6 20.0 51.1 8.6 5.8
Region 0.2635
Northeast 15.9 18.4 50.7 8.7 6.3
Midwest 14.8 21.9 49.1 8.2 6.0
South 14.6 19.9 50.5 8.6 6.4
West 14.6 19.4 52.7 8.0 5.2
SR DM 0.0365
No 14.4 19.8 51.1 8.6 6.2
Yes 16.7 20.0 48.7 8.4 6.2
SR HTN 0.0001
No 13.9 19.2 52.4 8.7 5.8
Yes 16.0 20.5 48.6 8.3 6.6
CVD 0.0151
No 14.5 20.0 51.0 8.5 6.1
Yes 17.1 18.9 48.4 8.7 6.9
FH CKD 0.5107
No 14.7 19.7 50.8 8.6 6.2
Yes 15.8 20.3 49.7 8.3 6.0
DM motherc 27.3 25.1 26.8 30.1 34.6 o0.0001
CKD, chronic kidney disease; CVD, cardiovascular disease; DM, diabetes mellitus; FH, family history; HTN, hypertension; KEEP, Kidney Early Evaluation Program; SR,
self-reported.
aValues are percents except as noted.
bw2-test for the difference in proportions of participants in each birth-weight category by different characteristics.
cPercent of participants with diabetic mothers in each birth-weight category.
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associated with higher risk of end-stage renal disease
compared with normal birth weight (3000–3499 g) for
women, but insignificant for men.11 However, when stratify-
ing the analysis on gender, the association of birth weight
with renal failure is similar in that study. Differences between
the two studies cannot be explained by sample size, because
our study included 2902 men and 9444 women, and the
study by Lackland et al.11 included 2676 men and 1014
women. An unlikely cause of bias would be that men were
more likely to remember their birth weight and thus report it
Table 2 | Prevalence of kidney-related outcomes across birth-weight categories by gender and race (%)a
Birth weight (g)
Populationb Kidney-related outcomes o2500 2500–2999 3000–3999 4000–4499 X4500 Pc
Male
All (n=2920) ACR X30 mg/g 15.8 11.3 9.4 8.3 11.8 0.0069
eGFR o60 ml per min per
1.73 m2
18.8 14.6 13.2 18.1 19.9 0.0033
CKDd 30.3 22.7 20.2 24.2 28.0 0.0003
White (n=1761) ACR X30 mg/g 17.0 11.1 7.8 7.3 9.1 0.0020
eGFR o60 ml per min per
1.73 m2
24.2 18.9 15.2 18.4 21.7 0.0210
CKDd 34.6 25.5 20.5 24.0 25.9 0.0012
African American
(n=741)
ACR X30 mg/g 15.7 13.8 11.7 7.7 16.7 0.3648
eGFR o60 ml per min per
1.73 m2
13.1 8.9 8.3 13.5 14.9 0.2307
CKDd 26.2 19.5 18.0 18.8 29.9 0.0925
Female
All (n=9444) ACR X30 mg/g 10.3 9.6 9.1 8.0 8.9 0.4717
eGFR o60 ml per min per
1.73 m2
18.7 17.1 17.5 19.8 17.7 0.4397
CKDd 26.3 24.4 24.2 25.7 24.6 0.4973
White (n=5343) ACR X30 mg/g 8.6 7.7 8.2 7.5 7.9 0.9533
eGFR o60 ml per min per
1.73 m2
23.3 21.7 21.1 24.5 19.4 0.3584
CKDd 29.4 27.3 26.8 29.3 26.1 0.5489
African American
(n=2802)
ACR X30 mg/g 11.3 12.1 10.1 7.0 11.4 0.3513
eGFR o60 ml per min per
1.73 m2
12.6 11.8 11.5 10.1 16.1 0.5245
CKDd 21.7 21.4 19.3 16.4 24.8 0.2616
ACR, albumin/creatinine ratio; CKD, chronic kidney disease; eGFR, estimated glomerular filtration rate.
aDenominators are number of people in each category of birth weight within each gender and race.
bOther races are not shown in the table.
cw2-test for the difference in prevalence of each kidney-related outcome in each category of birth weight within each gender and race.
deGFR o60 ml per min per 1.73 m2 or ACR X30 mg/g.
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Figure 2 | Odds ratios of CKD for men by birth weight: results
from multivariable logistic regression, adjusted for age; race;
education; insurance status; region; self-reported diabetes,
hypertension, or cardiovascular disease; family history of kidney
disease; and hypertension control.
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Figure 3 | Odds ratios of CKD for women by birth weight: results
from multivariate logistic regression, adjusted for age; race;
education; insurance status; region; self-reported diabetes,
hypertension, or cardiovascular disease; family history of kidney
disease; and hypertension control.
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more accurately. However, there is a difference in measuring
outcomes; our study outcome measures include early stages
of CKD and the study by Lackland et al. measured end-stage
renal disease. It is not clear whether there is a difference in
glomerular number and size by gender. One study found a
significantly lower nephron number for women than for men
among 140 adults aged 18–65 years, with no significant
difference in birth weight.4
One hypothesis to explain the gender differences in the
association of birth weight and CKD might be that estrogen
could counterbalance the impact of birth weight on the
progression of CKD, by decreasing the proliferative and
prosclerotic properties of mesangial cells and decreasing
collagen synthesis. Perhaps the impact of hypertension, which
typically occurs earlier in men, an early exposure to insulin
resistance, or angiotensin-mediated profibrotic effects of
testosterone made men more susceptible to the effects of a
reduced nephron number.15–18 However, our study might be
biased due to uncontrolled variations. For example, we did
not have data on gestational age and prematurity. In
addition, due to the gender disparity in the number of
participants in this study, unobserved differences may
influence the associations between gender.
In our study, the association between birth weight and
CKD was not significantly different between white subjects
and African Americans, although CKD prevalence was higher
among white subjects than among African Americans.
However, previous studies showed racial differences in the
association of birth weight with nephron number and the
association of nephron number with mean arterial pres-
sure.3,4 Among 106 subjects aged 30–65 years, the correlation
between birth weight and nephron number was stronger
among white subjects than African Americans (r¼ 0.555,
P¼ 0.003 for white subjects; r¼ 0.437, P¼ 0.002 for African
Americans); the correlation between nephron number and
mean arterial pressure was significant for white subjects but
not for African Americans (r¼0.455, P¼ 0.005 for whites;
r¼0.137, P¼ 0.382 for African Americans).3,4
Two strengths of our study are the sample size, which is
large enough to stratify analyses on gender, and diverse
populations including white, African American, and other
race/ethnicity. Our study has all the limitations of a cross-
sectional study. The association between birth weight and
CKD prevalence cannot be viewed as causative. Further, the
National Kidney Foundation KEEP participants represent a
volunteer population with a high risk of CKD, and the results
from this study do not generalize to the population as a
whole. In addition, about two-thirds of eligible KEEP
participants did not recall their birth weights, possibly also
limiting the generalizability of study results. Finally, self-
reported birth weight may also limit generalizability of the
study results. Age is a significant determinant of the accuracy
of self-reported birth weight.19,20 Correlations between actual
and self-reported birth weight were 0.64 for elderly people,19
0.86 for those aged 43–78 years, and 0.94 for those aged
43–50 years.20 The associations of self-reported birth weight
and prevalence of different diseases have been reported
previously.21–23
We believe that our study provides important new
information about the association of birth weight and
CKD, particularly for those at greatest risk of CKD. Studies
on the association of birth weight and CKD, and whether
factors such as socioeconomic status and hypertension
control could attenuate this association, may be needed.
Effort must be made to understand clinically the etiology of
the association of birth weight and CKD, and to identify
attenuating factors, in the interests of improving public
health.
MATERIALS AND METHODS
Subjects
In 1997, the initial KEEP program was piloted in 21 cities and
screened almost 900 individuals.24 In August 2000, KEEP was
officially launched nationwide. KEEP recruitment methods and
screening protocols have been described previously.24,25 All eligible
participants are required to give informed consent before they are
allowed to participate in the KEEP health screening program. Each
participant is asked to complete a health questionnaire; allow
measurements of weight, height, blood pressure, and blood sugar;
and submit blood and urine samples for additional off-site
biochemical testing. The current study included KEEP participants
screened from August 2000 through December 2005, from 48
National Kidney Foundation affiliates and 1245 screening programs
in 48 states.
Inclusion criteria
Eligible KEEP participants are aged 18 years or older and have
diabetes or hypertension or a first-degree relative with kidney
disease, diabetes, or hypertension. Of the 55 220 eligible KEEP
participants, 32% (17 546) reported their birth weights on the KEEP
questionnaires. Older participants and members of minority groups
were less likely to report birth weights.
Among the 17 546 participants who reported their birth weights,
820 aged older than 75 years were excluded, as were 3216 with
missing data for any outcome variable (serum creatinine, ACR, and
GFR) and 1146 with missing data for any independent variable (age,
race, education level, region of residence, any self-reported disease,
and family history of kidney disease). The final sample size was thus
12 364 participants aged 18–75 years.
To check the reliability of recall for birth weight, we examined
consistency in reporting birth weight at different times. Of the 2717
individuals who came to a second screening, 16.4% (445 of 2717)
recalled their birth weights at the first and the second screening. Of
these 445 individuals, 95.5% (425 of 445) recalled the same weight
or a different weight within 1 lb.
Measures
Serum creatinine was measured on the Olympus 400-640 alkaline
picrate assay at Satellite Laboratories from 1 August 2000 to 31
October 2005, and on the Abbott ARCHITECT c8000 using a
kinetic alkaline picrate assay at Central Laboratory Services from 1
November 2005 to the present. Both assays were calibrated to the
Roche P-Module creatinine enzymatic assay at the Cleveland Clinic
Research Laboratory, which has been shown to be equivalent to
creatinine reference values.26 For Satellite Laboratories, creatinine
values were subtracted by 0.04 to obtain standardized values and for
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the Central Laboratory Services, creatinine values were multiplied by
1.07 and then subtracted by 0.18.
Measures for kidney-related outcomes included prevalence of
ACR 30 mg/g or greater, estimated GFR less than 60 ml per min per
1.73 m2, and CKD. CKD was defined by estimated GFR less than
60 ml per min per 1.73 m2 or ACR 30 mg/g or greater. GFR was
estimated using the re-expressed Modification of Diet in Renal
Disease Study Equation (175 (calibrated serum creatinine)1.154
age0.203) and adjusted by multiplying by 0.742 for women and 1.21
for African Americans.27
Birth weight was recorded in pounds in the questionnaire and
converted to grams for analysis. We categorized the study
population by five birth-weight groups: less than 2500 g,
2500–2999, 3000–3999, 4000–4499, and X4500 g . Other covariates
used in the analysis were age; gender; race; insurance coverage
(yes or no); more than high school education (yes or no);
region (northeast, midwest, south, or west); self-reported diabetes,
hypertension, or cardiovascular disease; family history of kidney
disease; and hypertension control (systolic blood pressure less than
140 mm Hg and diastolic blood pressure less than 90 mm Hg).
Statistical methods
Univariate analyses were used to compare covariates and kidney
disease outcomes across the five birth-weight categories. We
performed multivariable logistic regression to examine the associa-
tion of birth weight and CKD after adjustment for age; gender; race;
insurance coverage; education; region; and prevalence of diabetes,
hypertension, cardiovascular disease; and family history of kidney
disease. Interactions between birth-weight categories and gender or
race were examined. SAS version 9.1 was used for the analyses.28
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